EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.24.75 | Abscess |
2467987 |
Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. |
therapeutic application unassigned |
1 0 |
3.4.24.75 | Abscess |
5683827 |
Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice. |
therapeutic application unassigned |
4 0 |
3.4.24.75 | Blood-Borne Infections |
12543658 |
Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. |
therapeutic application unassigned |
2 0 |
3.4.24.75 | Catheter-Related Infections |
15215130 |
Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. |
therapeutic application unassigned |
2 0 |
3.4.24.75 | Catheter-Related Infections |
24366730 |
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models. |
ongoing research therapeutic application unassigned |
3 4 0 |
3.4.24.75 | Communicable Diseases |
4265118 |
Lysostaphin: model for a specific enzymatic approach to infectious disease. |
ongoing research therapeutic application unassigned |
1 4 0 |
3.4.24.75 | Communicable Diseases |
27713293 |
Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. |
therapeutic application unassigned |
4 0 |
3.4.24.75 | Endocarditis |
5628090 |
Studies in experimental staphylococcal endocarditis in dogs. VI. Treatment with lysostaphin. |
therapeutic application unassigned |
4 0 |
3.4.24.75 | Endocarditis |
9624475 |
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. |
ongoing research therapeutic application unassigned |
2 4 0 |
3.4.24.75 | Endocarditis |
10390235 |
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. |
diagnostic usage therapeutic application unassigned |
3 4 0 |